On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...